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Abstract
Netrin-G ligand-3 (NGL-3) is a postsynaptic adhesion molecule known to directly interact with
the excitatory postsynaptic scaffolding protein postsynaptic density-95 (PSD-95) and trans-
synaptically with leukocyte common antigen-related (LAR) family receptor tyrosine phospha-
tases to regulate presynaptic differentiation. Although NGL-3 has been implicated in the regu-
lation of excitatory synapse development by in vitro studies, whether it regulates synapse
development or function, or any other features of brain development and function, is not
known. Here, we report that mice lacking NGL-3 (Ngl3−/− mice) show markedly suppressed
normal brain development and postnatal survival and growth. A change of the genetic back-
ground of mice from pure to hybrid minimized these developmental effects but modestly sup-
pressed N-methyl-D-aspartate (NMDA) receptor (NMDAR)-mediated synaptic transmission
in the hippocampus without affecting synapse development, α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptor (AMPAR)-mediated basal transmission, and pre-
synaptic release. Intriguingly, long-term depression (LTD) was near-completely abolished in
Ngl3−/− mice, and the Akt/glycogen synthase kinase 3β (GSK3β) signaling pathway, known
to suppress LTD, was abnormally enhanced. In addition, pharmacological inhibition of Akt,
but not activation of NMDARs, normalized the suppressed LTD in Ngl3−/− mice, suggesting
that Akt hyperactivity suppresses LTD. Ngl3−/− mice displayed several behavioral abnormali-
ties, including hyperactivity, anxiolytic-like behavior, impaired spatial memory, and enhanced
seizure susceptibility. Among them, the hyperactivity was rapidly improved by pharmacologi-
cal NMDAR activation. These results suggest that NGL-3 regulates brain development, Akt/
GSK3β signaling, LTD, and locomotive and cognitive behaviors.
Introduction
Synaptic adhesion molecules regulate diverse aspects of synapse development, function, and
plasticity. A large number of synaptic adhesion molecules have been identified, typified by
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members of the neuroligin and neurexin families [1–16]. These molecules are thought to regu-
late neuronal synapses through diverse mechanisms, including trans-synaptic adhesions and
cytoplasmic interactions with scaffolding and signaling proteins, although in vivo evidence in
support of these mechanisms is generally limited.
Netrin-G ligands (NGLs; also known as LRRC4s) are a family of postsynaptic adhesion mol-
ecules with three known members: NGL-1/LRRC4C, NGL-2/LRRC4, and Netrin-G ligand-3
(NGL-3)/LRRC4B [17–19]. NGL-3 interacts with presynaptic leukocyte common antigen-
related (LAR) family receptor tyrosine phosphatases (LAR-RPTPs; LAR, protein tyrosine phos-
phatase σ [PTPσ], and protein tyrosine phosphatase δ [PTPδ]) [20, 21], which have been impli-
cated in diverse psychiatric disorders and are known to regulate both early neurodevelopmental
processes and postnatal synapse development [1, 4]. In addition to NGL-3, LAR-RPTPs have
recently been shown to interact with several other postsynaptic adhesion molecules, including
TrkC, interleukin 1 receptor accessory protein like 1 (IL1RAPL1), interleukin 1 receptor acces-
sory protein (IL1RAcP), Slit- and Trk-like proteins (Slitrk1–5), synaptic adhesion-like molecule
3 (SALM3), and SALM5 [19, 21–30]. Although these trans-synaptic adhesion complexes consti-
tute a rapidly expanding group of synaptic organizers, little is known about their differential
functions. In particular, it is unclear which trans-synaptic complexes are more important for
early neurodevelopmental processes versus postnatal synapse development.
Intracellularly, NGL-3 directly interacts with postsynaptic density-95 (PSD-95), an abun-
dant excitatory postsynaptic scaffolding protein, through its C-terminal PDZ-binding motif
[31], and induces postsynaptic clustering of PSD-95, N-methyl-D-aspartate (NMDA) recep-
tors (NMDARs), and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) recep-
tors (AMPARs) [22], strongly implicating NGL-3 in the regulation of excitatory synapse
development and function. For instance, NGL-3 overexpression and knockdown in cultured
neurons result in bidirectional changes in the number of excitatory synapses and spontaneous
excitatory synaptic transmission [22]. However, whether NGL-3 regulates synapse develop-
ment in vivo remains unclear. In addition, it is not known whether NGL-3 regulates other syn-
aptic and higher brain functions, such as synaptic transmission, synaptic plasticity, brain
excitability, and specific behaviors.
In the present study, we found that Ngl3/Lrrc4b knockout (KO) in a pure C57BL/6J genetic
background (termed Ngl3−/−(B6) mice) decreases birth rate, postnatal growth and survival, and
brain development, whereas Ngl3 KO in a hybrid genetic background (Ngl3−/−(Hyb) mice) does
not induce these neurodevelopmental features. Instead, these latter mice display modestly
reduced NMDAR- but not AMPAR-dependent synaptic transmission. Intriguingly, long-term
depression (LTD) was near-completely abolished in the hippocampus of both Ngl3−/− mice,
and the Akt/glycogen synthase kinase 3β (GSK3β) signaling pathway, known to suppress LTD,
was abnormally enhanced. Importantly, Akt inhibition normalized the suppressed LTD in the
Ngl3−/− hippocampus, suggesting that enhanced Akt/GSK3β phosphorylation suppresses LTD
and that NGL-3 regulates Akt/GSK3β signaling. Behaviorally, these Ngl3−/−(Hyb) mice show
hyperactivity that is responsive to NMDAR activation, as well as anxiolytic-like behavior and
impaired spatial learning and memory. These results implicate NGL-3 in the regulation of
brain development and excitability, Akt/GSK3β signaling, LTD, and behaviors in vivo.
Results
Ngl3−/−(B6) mice show decreased birth rate and suppressed postnatal
growth, survival, and brain development
To investigate in vivo functions of NGL-3, we first generated Ngl3−/− mice in a C57BL/6J back-
ground (Ngl3−/−(B6)) by replacing exon 2 of the Ngl3 gene (which together with exon 3 encodes
NGL-3 in brain development, synaptic plasticity, and behaviors
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the entire NGL-3 protein) with a β-galactosidase + neomycin resistance (β-geo) cassette. Ngl3
KO was confirmed by PCR-based genotyping and immunoblot analysis (S1 Fig).
Ngl3−/−(B6) mice showed a reduced Mendelian ratio of approximately 12% compared with
the expected approximately 25%, as shown by PCR genotyping performed at approximately
postnatal day 7 (P7), suggesting that Ngl3 KO causes approximately 50% embryonic lethality.
In addition, Ngl3−/−(B6) mice showed reduced postnatal survival, exhibiting a decline in sur-
vival rate beginning at about P18 and reaching approximately 50% of wild-type (WT) mice at
about P30 (Fig 1A). Surviving Ngl3−/−(B6) mice also showed reduced postnatal growth, as evi-
denced by decreased whole-body weights (Fig 1B) compared with WT and heterozygous
Ngl3+/−(B6) mice. In addition, the timing of weaning had to be shifted about one week (from
approximately 3 to 4 weeks) and, after weaning, Ngl3−/−(B6) mice had difficulty eating food pel-
lets from the overhead grid and usually required the food to be placed on the cage floor.
Hematoxylin–eosin (HE) staining of Ngl3−/−(B6) brain slices at 10 weeks revealed substantial
alterations in the gross morphology of the brain, as exemplified by the enlarged size of lateral
and third ventricles (Fig 1C). Given these anatomical alterations, we opted not to measure
additional details of brain morphology, such as total brain or individual brain-region sizes.
These results collectively indicate that Ngl3 KO in a pure C57BL/6J genetic background
decreases birth rate and suppresses postnatal growth, survival, and brain development.
Ngl3−/−(Hyb) mice show normal birth and postnatal growth and survival,
and a largely normal brain morphology
To overcome the practical difficulties of producing sufficient numbers of Ngl3−/− mice for addi-
tional experiments, we shifted the genetic background of Ngl3−/− mice from pure C57BL/6J to a
hybrid 129Sv;C57BL/6J (50:50) genetic background (termed Ngl3−/−(Hyb) hereafter). The two orig-
inal mouse lines (C57BL/6J and 129Sv) were maintained independently before crossing and pro-
ducing mice for experiments. We found that these hybrid Ngl3−/−(Hyb) mice displayed normal
birth rates, based on Mendelian ratios, and normal postnatal growth and survival. However, brain
weight measurements and HE staining showed that the overall size of the brains from these mice
was slightly reduced, although body weights were also decreased (Fig 1D and 1E).
An analysis of microtubule associated protein 2 (MAP2)- and Nissl-stained Ngl3−/− slices
revealed that the gross morphology of the Ngl3−/−(Hyb) brain was largely normal, except for an
apparent decrease in the size of the thalamus (Fig 1F and 1G). Levels of NGL-3 relatives
(NGL-1 and NGL-2) were normal in the Ngl3−/−(Hyb) brains (3 and 10 weeks), although levels
of PTPδ, a trans-synaptic partner of NGL-3, were reduced (S2 Fig). Lastly, we examined the
NGL-3 expression pattern in Ngl3−/−(Hyb) mice. NGL-3 protein expression, revealed by moni-
toring NGL-3–β-galactosidase fusion proteins using X-gal staining (S1 Fig), was detected in
various brain regions, including the neocortex, hippocampus, striatum, thalamus, hypothala-
mus, and cerebellum (Fig 1H, S3A Fig).
Normal synapse development and basal excitatory transmission in the
Ngl3−/−(Hyb) hippocampus
To determine whether NGL-3 regulates synapse development and function in vivo, we first
measured synaptic transmission in the hippocampus of Ngl3−/−(Hyb) and Ngl3−/−(B6) mice.
Both excitatory and inhibitory synaptic transmissions were normal in Ngl3−/−(Hyb) Cornu
Ammonis 1 (CA1) pyramidal neurons, as shown by the frequency and amplitude of miniature
excitatory postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents
(mIPSCs), mainly mediated by AMPARs and GABA receptors, respectively (Fig 2A; S4A Fig).
Ngl3−/−(B6) CA1 pyramidal neurons also showed normal mEPSCs (Fig 2B). In line with these
NGL-3 in brain development, synaptic plasticity, and behaviors
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results, immunofluorescence signals for the excitatory and inhibitory presynaptic markers
vesicular glutamate transporter 1(VGlut1) and vesicular GABA transporter (VGAT), respec-
tively, were largely normal in subregions of the Ngl3−/−(Hyb) hippocampus (S3B Fig).
In field recordings, Ngl3−/−(Hyb) and Ngl3−/−(B6) Schaffer collateral-CA1 pyramidal
(SC-CA1) synapses showed a normal input-output relationship, which is mainly mediated by
AMPARs, and paired-pulse facilitation (Fig 2C–2F), suggestive of unaltered basal excitatory
transmission and presynaptic release probability. These results collectively suggest that Ngl3
KO has minimal effects on excitatory synapse development and AMPAR-mediated excitatory
synaptic transmission in the hippocampus.
Fig 1. Ngl3 deletion in mice decreases birth rate and suppresses postnatal growth, survival, and brain development. (A) Reduced survival of Ngl3−/−(B6)
(KO) mice during the first 8 postnatal weeks. n = 61 mice for WT, 118 for HT, and 30 for KO. (B) Substantially reduced body weights in Ngl3−/−(B6) mice
compared with WT mice. Note that body weights of Ngl3+/−(B6) mice are moderately reduced. n = 61 mice for WT, 118 for HT, and 30 for KO. (C) Altered
gross morphology of the Ngl3−/−(B6) brain (10 weeks), revealed by HE staining. Note that the sizes of ventricles are increased in Ngl3−/−(B6) slices. Scale bar, 1
mm. (D) Moderate reductions in both body and brain weights, with unaltered brain/body weight ratios, in Ngl3−/−(Hyb) mice (3–5 months). KO-H, Ngl3−/−
(Hyb). n = 21 mice for WT and 18 for KO, ���P< 0.001, ns, not significant, Student t test. (E) Moderately reduced overall size of the Ngl3−/−(Hyb) brain (10
weeks), as shown by HE staining. Scale bar, 1 mm. (F and G) Reduced brain size in Ngl3−/−(Hyb) mice (10 weeks), with an apparent decrease in the size of the
thalamus, as shown by Nissl (cell body marker) + MAP2 (dendritic marker) staining. Nissl-only images are also shown for clarity. Scale bar, 2 mm for MAP2
and Nissl, and 0.5 mm for Nissl only. (H) NGL-3 expression patterns, as revealed by X-gal staining of Ngl3−/−(Hyb) brain slices (8–10 weeks). Scale bar, 1 mm.
Primary data can be found in S3_Data. Cb, cerebellum; Ctx, cortex; HE, hematoxylin–eosin; Hp, hippocampus; HT, heterozygous; HT-B, heterozygous,
C57BL/6; Hyp, hypothalamus; KO, knockout; KO-B, knockout, C57BL/6; KO-H, knockout, hybrid; MAP2, microtubule associated protein 2; NGL-3, Netrin-G
ligand-3; ns, not significant; St, striatum; Th, thalamus; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g001
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Ngl3 KO moderately suppresses NMDAR-dependent synaptic transmission
and long-term potentiation but near-completely suppresses LTD in the
hippocampus
Because artificially clustered NGL-3 has been shown to co-cluster with NMDARs in cultured
hippocampal neurons [22], we next attempted to determine whether Ngl3 KO affects
NMDAR-mediated synaptic transmission and NMDAR-dependent synaptic plasticity. Patch-
clamp recordings showed significantly reduced NMDAR function at Ngl3−/−(Hyb) SC-CA1 syn-
apses, as evidenced by the decrease in the ratio of evoked NMDAR-to-AMPAR–mediated
excitatory postsynaptic currents (EPSCs) (NMDA/AMPA ratio) (Fig 3A). Ngl3−/−(B6) SC-CA1
synapses, however, did not show a change in the NMDA/AMPA ratio (Fig 3B), likely attribut-
able to the differential impacts of Ngl3 KO on brain development under different genetic back-
grounds. In addition, NMDAR-dependent mEPSCs from Ngl3−/−(Hyb) mice measured in the
presence of AMPAR blocker 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline
(NBQX) and under a low-magnesium condition indicated decreases in the amplitude and fre-
quency of NMDAR-dependent mEPSCs (S4B Fig). The decreased frequency of NMDAR
mEPSCs, given the normal frequency of AMPAR mEPSCs (Fig 2A), appears to be caused by
Fig 2. Ngl3−/−(Hyb) and Ngl3−/−(B6) mice show normal excitatory spontaneous and basal synaptic transmission. (A) Normal AMPAR mEPSCs in
hippocampal CA1 pyramidal neurons of Ngl3−/−(Hyb) mice (P21–23). n = 15 cells from three mice for WT and KO; ns, not significant, Student t test. (B)
Normal AMPAR mEPSCs in hippocampal CA1 pyramidal neurons of Ngl3−/−(B6) mice (P22–25). n = 15 cells from three mice for WT and 14, 4 for KO; ns, not
significant, Student t test. (C and E) Normal input-output relationship and paired-pulse ratio at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P28–30),
as shown by fEPSP slopes plotted against either fiber volley amplitudes or inter-pulse intervals. n = 10 slices from three mice for WT and KO for both input-
output and paired-pulse ratio, two-way ANOVA with Bonferroni test. (D and F) Normal input-output relationship and paired-pulse ratio at hippocampal
SC-CA1 synapses of Ngl3−/−(B6) mice (P28–30), as shown by fEPSP slopes plotted against either fiber volley amplitudes or inter-pulse intervals. n = 7 slices from
two mice for WT and KO for both input-output and paired-pulse ratio, two-way ANOVA with Bonferroni test. Primary data can be found in S3 Data.
AMPAR, AMPA receptor; CA1, Cornu Ammonis 1; fEPSP, field excitatory postsynaptic potential; KO, knockout; KO-B, knockout, C57BL/6; KO-H, knockout,
hybrid; mEPSC, miniature excitatory postsynaptic current; ns, not significant; P, postnatal day; SC-CA1, Schaffer collateral-CA1 pyramidal; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g002
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the reduced amplitude of NMDAR mEPSCs, which makes peak sizes smaller than the detec-
tion threshold. The normal input/output curve of evoked EPSCs and normal AMPAR
mEPSCs, together with the suppressed NMDAR mEPSCs, in the Ngl3−/−(Hyb) hippocampus
strongly suggest a selective decrease in NMDAR currents.
In line with the moderately reduced NMDAR function, long-term potentiation (LTP)
induced by high-frequency stimulation (HFS) was significantly suppressed (33%–40%) at
Ngl3−/−(Hyb) and Ngl3−/−(B6) SC-CA1 synapses (Fig 3C and 3D). Intriguingly, LTD induced by
low-frequency stimulation (LFS) was almost completely abolished at both Ngl3−/−(Hyb) and
Ngl3−/−(B6) SC-CA1 synapses (Fig 3E and 3F). In contrast, metabotropic glutamate receptor
(mGluR)-dependent LTD was not affected at Ngl3−/−(Hyb) SC-CA1 synapses (S4C Fig). These
results collectively suggest that Ngl3 KO leads to moderate suppression of NMDAR-dependent
synaptic transmission and LTP but near-complete suppression of LTD in the hippocampus.
Ngl3 KO does not affect synaptic or surface levels of NMDARs in the brain
but strongly activates Akt and inhibits GSK3β
In order to explore the mechanisms underlying the moderate decreases in NMDAR-mediated
synaptic transmission and LTP and the near-complete elimination of LTD in Ngl3−/−(Hyb)
mice (Fig 3), we tested whether there are any changes in the synaptic levels of NMDAR sub-
units in the Ngl3−/− brain. However, Ngl3 KO did not affect the synaptic levels of NMDAR sub-
units, as shown by the immunoblot analysis of Glutamate, NMDAR subunit 1 (GluN1),
Glutamate, NMDAR subunit 2A (GluN2A), and Glutamate, NMDAR subunit 2B (GluN2B) in
the crude synaptosomal fraction of WT and Ngl3−/−(Hyb) whole brains at both 3 and 10 postna-
tal weeks (Fig 4A and 4B). In addition, Ngl3 KO did not affect the surface levels of the GluN1
subunit of NMDARs (Fig 4C), suggesting that surface trafficking of NMDARs was not
affected.
The lack of changes in the synaptic and surface levels of NMDAR subunits in the Ngl3−/−(Hyb)
brain (Fig 4) suggests the possibility that Ngl3 KO may affect NMDAR-dependent synaptic
transmission and synaptic plasticity (LTP and LTD) by altering the phosphorylation levels of
NMDARs or the signaling pathways in the downstream of NMDAR activation [32]. To this end,
we first measured phosphorylation levels of NMDAR subunits at known sites and found a signif-
icant decrease in the phosphorylation of GluN1 at Ser-896 but not in GluN2B at Ser-1284, Tyr-
1336, Tyr-1472, or Ser-1480 in the Ngl3−/−(Hyb) brain (Fig 4A and 4B). Given that the GluN1
phosphorylation at Ser-896 promotes the surface trafficking of GluN1 from the endoplasmic
reticulum [33] but that our Ngl3 KO does not lead to a decrease in surface levels of GluN1 (Fig
4C), a compensatory change, such as decreased endocytosis of NMDARs, might have occurred
to normalize the surface levels of NMDARs in the mutant neurons.
We next measured changes in the total and phosphorylation levels of known signaling mol-
ecules in the Ngl3−/−(Hyb) brain (3 weeks). We found a strong increase in the phosphorylation
levels of the serine/threonine kinase Akt (also known as protein kinase B) at both Ser-308 and
Ser-473 (Fig 4D), known to lie in the downstream of phosphatidyl inositol 3 kinase/3-phos-
phoinositide-dependent protein kinase 1 (PI3K/PDK1) and mammalian target of rapamycin
(mTOR) complex 2 (mTORC2), respectively [34]. Total Akt levels were modestly increased.
Unexpectedly, there were no changes in the total and phosphorylation levels of PI3K (Tyr-
458) and mTOR (Ser-2448), which lie in the upstream and downstream of Akt, respectively,
suggesting that the observed increase in Akt activity may not involve the canonical PI3K-Akt-
mTOR pathway or that PI3K/mTOR activity was normalized by compensation. Intriguingly,
however, there was a strong increase in the phosphorylation (a measure of inactivation), but
not total, levels of GSK3β at Ser-9, a serine/threonine kinase in the downstream of Akt known
NGL-3 in brain development, synaptic plasticity, and behaviors
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to promote LTD when activated (dephosphorylated) [35, 36] (Fig 4D). Total and phosphoryla-
tion levels of protein kinase C (PKC), known to phosphorylate and stimulate NMDAR func-
tion [37], were not affected. These results suggest that Ngl3 KO leads to strong increases in the
phosphorylation of Akt and GSK3β.
Inhibition of Akt, but not activation of NMDAR, normalizes the
suppressed LTD in the Ngl3−/−(Hyb) hippocampus
The strongly increased phosphorylation of Akt and GSK3β in the Ngl3−/−(Hyb) brain (Fig 4D)
suggests the possibility that altered Akt/GSK3β signaling may induce the near-complete elimi-
nation of LTD in the hippocampus (Fig 3). To this end, we measured LTD induced by LFS in
at Ngl3−/−(Hyb) hippocampal SC-CA1 synapses in the presence of the Akt inhibitor IV (10 μM)
(Fig 5A), known to inhibit Akt phosphorylation at both Ser-308 and Ser-473 [38–40]. Surpris-
ingly, this Akt inhibition normalized the suppressed LFS-LTD at Ngl3−/−(Hyb) SC-CA1 synap-
ses, as compared with vehicle-treated Ngl3−/−(Hyb) synapses. In contrast, this Akt inhibition did
Fig 3. Moderate suppression of NMDAR-dependent synaptic transmission and LTP but near-complete suppression of LTD in the Ngl3−/− hippocampus. (A)
Reduced NMDAR function at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P19–22), as shown by the NMDA/AMPA EPSC ratio. Note that the decay kinetics of
NMDAR currents are normal. n = 14 cells from seven mice for WT and 16, 9 for KO; �P< 0.05, ns, not significant, Student t test. (B) Normal NMDAR function at Ngl3−/
−(B6) hippocampal SC-CA1 synapses (P19–23), as shown by the NMDA/AMPA ratio. n = 18 cells from eight mice for WT and 16, 10 for KO; ns, not significant, Student t
test. (C) Suppressed LTP induced by high-frequency stimulation (100 Hz, 1 second) at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P25–33). n = 19 slices from 11
mice for WT and 16, 8 for KO; �P< 0.05, Student t test. (D) Suppressed LTP induced by high-frequency stimulation (100 Hz, 1 second) at hippocampal SC-CA1 synapses
of Ngl3−/−(B6) mice (P23–26). n = 15 slices from nine mice for WT and 15, 10 for KO; �P< 0.05, Student t test. (E) Near-complete suppression of LTD induced by low-
frequency stimulation (1 Hz, 15 minutes) at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P16–20). n = 12, 6 for WT and 10, 6 for KO; ���P< 0.001, Student t test.
(F) Near-complete suppression of LTD induced by low-frequency stimulation (1 Hz, 15 minutes) at hippocampal SC-CA1 synapses of Ngl3−/−(B6) mice (P17–21). n = 9, 6
for WT and 10, 6 for KO; ���P< 0.001, Student t test. Primary data can be found in S3 Data. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; EPSC,
excitatory postsynaptic current; fEPSP, field excitatory postsynaptic potential; HFS, high-frequency stimulation; KO, knockout; KO-B, knockout, C57BL/6; KO-H,
knockout, hybrid; LTD, long-term depression; LTP, long-term potentiation; NMDA, N-methyl-D-aspartate; NMDAR, NMDA receptor; ns, not significant; P, postnatal
day; SC-CA1, Schaffer collateral-CA1 pyramidal; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g003
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Fig 4. Ngl3 KO does not affect synaptic or surface levels of NMDARs in the brain but strongly activates Akt and inhibits GSK3β. (A and B) Ngl3 KO does
not affect total and phosphorylation levels of NMDAR subunits, as shown by immunoblot analyses with whole-brain crude synaptosomes from Ngl3−/−(Hyb)
mice (3 and 10 weeks). KO levels of the indicated proteins normalized to α-tubulin levels were further normalized to WT levels normalized to α-tubulin. n = 4
mice for WT and KO. (C) Ngl3 KO does not affect surface levels of GluN1 or GluA1, as shown by biotinylated surface levels of the indicated proteins from the
total lysates of the Ngl3−/−(Hyb) hippocampus (3 weeks). n = 5 mice for WT and 6 mice for KO. (D) Ngl3 KO leads to strong increases in the phosphorylation
levels of Akt (Ser-308 and Ser-473) and GSK3β (Ser-9), as shown by the immunoblot analysis of the indicated proteins with whole-brain crude synaptosomes of
Ngl3−/−(Hyb) mice (3 weeks). n = 4 mice for WT and KO (except for n = 3 and 4 for pAkt-Ser-308). Primary data can be found in S3 Data. GluA1, Glutamate,
AMPAR subunit 1; GluA2, Glutamate, AMPAR subunit 2; GluN1, Glutamate, NMDAR subunit 1; GSK3β, glycogen synthase kinase 3β; KO, knockout; mTOR,
mammalian target of rapamycin; NMDAR, NMDA receptor; pAkt, phosphorylated Akt; p-GluN1, phosphorylated GluN1; p-GluN2B, phosphorylated
GluN2B; p-GSK3β, phosphorylated GSK3β; PKC, protein kinase C; p-PKC, phosphorylated PKC; p-PI3K, phosphorylated PI3K; PI3K, phosphatidyl inositol 3
kinase; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g004
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not affect WT LFS-LTD. These results suggest that the enhanced Akt/GSK3β phosphorylation
may suppress LTD in the Ngl3−/−(Hyb) hippocampus.
Because NMDAR-mediated synaptic transmission and LTP were reduced in the Ngl3−/
−(Hyb) hippocampus (Fig 3), and reduced NMDAR function can contribute to NMDAR-
dependent LTP and LTD [36, 41], we tested if the suppressed LTP and LTD could be normal-
ized by the NMDAR agonist D-cycloserine (DCS). However, neither LTP nor LTD was nor-
malized by DCS (20 μM) at Ngl3−/−(Hyb) hippocampal SC-CA1 synapses (Fig 5B and 5C).
These results suggest that the decreased NMDAR-mediated synaptic transmission does not
contribute to the suppressed LTP or LTD in the Ngl3−/−(Hyb) hippocampus.
Ngl3−/− mice display hyperactivity, anxiolytic-like behavior, and impaired
learning and memory
Ngl3 KO leads to the alteration of LTP and LTD (Fig 3), which would affect the formation and
function of neural circuits in the Ngl3−/− brain. In addition, although NGL-3 has not been directly
implicated in any brain disorders, its presynaptic binding partners such as LAR-RPTPs have
been strongly associated with various brain disorders [1, 4], including restless leg syndrome [42–
44], ADHD [45], autism spectrum disorder (ASD) [46], and bipolar disorder [47]. We thus tested
if Ngl3 KO leads to any behavioral abnormalities in Ngl3−/−(Hyb) and Ngl3−/−(B6) mice.
Ngl3−/−(Hyb) mice showed strong hyperactivity in the open-field test and spent more time in
the center region of the open-field arena compared with WT mice (Fig 6A). Ngl3−/−(B6) mice
showed similar open-field hyperactivity but did not display a change in the center time (Fig 6B).
Mouse movements were then monitored in a home-cage–like environment (Laboras
cages), which becomes a familiar environment after a few hours of initial habituation, for two
consecutive days. Under these conditions, Ngl3−/−(Hyb) mice also showed strong hyperactivity,
especially on the second day during the light-off period (Fig 6C). In addition, they showed
increased rearing, a measure of vertical hyperactivity, but exhibited reduced climbing activity
(Fig 6D). Ngl3−/−(B6) mice showed a similar increase in rearing and a decrease in climbing but
no detectable hyperactivity in Laboras cages (Fig 6E and 6F). These results collectively suggest
that Ngl3 KO leads to hyperactivity in both novel and familiar environments.
Ngl3−/−(Hyb) mice were also hyperactive on the elevated plus maze (Fig 7A), similar to their
behavior in the open-field arena. In addition, Ngl3−/−(Hyb) mice showed reduced anxiety-like
behavior, as evidenced by the increased time spent in open arms and decreased time spent in
closed arms in the elevated plus maze (Fig 7A). This anxiolytic-like behavior in the elevated
plus maze is consistent with the increased time spent in the center region of the open-field
arena (Fig 6A). However, Ngl3−/− mice acted normally in the light-dark chamber test (Fig 7B),
suggesting that their anxiolytic-like behaviors manifest under specific conditions. Ngl3−/−(B6)
mice were less anxious on the elevated plus maze (Fig 7C) as well as in the light-dark apparatus
(Fig 7D), displaying stronger anxiolytic-like phenotypes as compared with Ngl3−/−(Hyb) mice.
These results collectively suggest that Ngl3 KO leads to anxiolytic-like behaviors in mice.
An analysis of Ngl3−/−(Hyb) mice for autistic-like behaviors revealed normal social interac-
tions in the three-chamber test (S5A Fig). These mice also showed normal repetitive behaviors,
including self-grooming and marble burying (S5B Fig). Ngl3−/−(B6) mice also acted normally
in the three-chamber test (S5C Fig).
Given that Ngl3−/− mice show altered synaptic plasticity in the hippocampus (Fig 3), we
next examined learning and memory in these mice. Ngl3−/−(Hyb) mice showed impaired learn-
ing and memory in the Morris water maze test during learning, probe, and reversal phases
(Fig 8A–8C). Similar impairments were observed in Ngl3−/−(B6) mice (Fig 8D–8F). In contrast,
Ngl3−/−(Hyb) mice showed normal memory in novel-object recognition and fear conditioning
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Fig 5. Inhibition of Akt, but not activation of NMDAR, normalizes the suppressed LTD in the Ngl3−/−(Hyb) hippocampus. (A) Akt inhibitor IV normalizes
the suppressed LTD induced by LFS (1 Hz, 15 minutes) at hippocampal SC-CA1 synapses in Ngl3−/−(Hyb) mice (P16–20). n = 8 slices from three mice for
WT-V, 8, 3 for WT-D, 8, 3 for KO-V, and 7, 3 for KO-D; ��P< 0.01, ���P< 0.001, ns, not significant, two-way ANOVA with Bonferroni test. (B) DCS has no
effect on LTP induced by HFS (100 Hz, 1 second) at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P26–32). n = 9 slices from three mice for WT-V,
WT-D, KO-V, and KO-D; ��P< 0.01, ns, not significant, two-way ANOVA with Bonferroni test. (C) DCS has no effect on LTD induced by LFS (1 Hz, 15
minutes) at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P16–20). n = 7 slices from six mice for WT-V, 7, 4 for WT-D, 6, 5 for KO-V, and 6, 4 for
KO-D; ���P< 0.001, ns, not significant, two-way ANOVA with Bonferroni test. Primary data can be found in S3 Data. DCS, D-cycloserine; fEPSP, field
excitatory postsynaptic potential; HFS, high-frequency stimulation; KO-D, knockout, drug; KO-V, knockout, vehicle; LFS, low-frequency stimulation; LTD,
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tests (S5D and S5E Fig). Ngl3−/−(B6) mice also performed normally in the novel-object recogni-
tion test (S5F Fig). Ngl3−/−(Hyb) mice showed impaired motor coordination and learning in the
rotarod test (S5G Fig). These results suggest that Ngl3 KO leads to deficits in specific learning
and memory behaviors.
Ngl3 heterozygosity minimally affects synaptic functions and behaviors in
mice
To determine whether Ngl3 deletion has dose-dependent impacts, we first tested if Ngl3 het-
erozygosity affects synaptic transmission and plasticity. We used brain slices from Ngl3+/–(B6)
mice, which are likely to display stronger synaptic phenotypes relative to Ngl3+/–(Hyb) mice
based on their stronger neurodevelopmental phenotypes. Heterozygous Ngl3+/–(B6) mice, how-
ever, showed normal spontaneous and basal synaptic transmission in the hippocampus, as
shown by mEPSCs and mIPSCs in CA1 pyramidal neurons and input-output and paired-pulse
ratios at SC-CA1 synapses (S6A–S6D Fig). NMDAR function was also normal, as measured
by the NMDA/AMPA ratio and LTP induced by HFS at Ngl3+/– SC-CA1 synapses, although
these parameters tended to decrease (S6E and S6F Fig).
Behaviors of Ngl3+/–(B6) mice were largely normal, although these mice showed moderate
hypoactivity (not hyperactivity) in the open-field test and moderate anxiolytic-like behavior in
the light-dark test (S7 Fig). These results suggest that heterozygosity of Ngl3 has minimal
effects on synaptic transmission and plasticity and behaviors in mice.
Enhanced hippocampal excitation and susceptibility to induced seizures in
Ngl3−/−(Hyb) mice
Altered NMDAR function and synaptic plasticity (LTP and LTD) at Ngl3−/−excitatory synap-
ses would disrupt the balance between excitation and inhibition at the synapse, neuron, and
circuit levels, known to be required for normal brain functions and behaviors [48–51].
To this end, we first tested whether Ngl3 is expressed in inhibitory GABAergic neurons in
addition to excitatory glutamatergic neurons by double fluorescence in situ hybridization.
Ngl3 mRNAs were detected in both excitatory and inhibitory neurons in brain regions, includ-
ing the cortex and hippocampus (S8 Fig). These results suggest the possibility that NGL-3 reg-
ulates excitatory synapse development and function in inhibitory neurons and the balance
between excitatory and inhibitory neurons.
To further explore this possibility, we next examined network activities in the Ngl3−/−(Hyb)
hippocampus by measuring spontaneous EPSCs (sEPSCs) and sIPSCs in CA1 pyramidal neu-
rons. This analysis revealed increases in the frequency and amplitude of sEPSCs, although the
latter was increased to a lesser extent (Fig 9A); by contrast, the frequency and amplitude of
mEPSCs were normal in the same neuronal population (Fig 2A). sIPSCs were normal in
Ngl3−/−(Hyb) CA1 pyramidal neurons (Fig 9B), similar to the mIPSC results (S4A Fig). These
results suggest that Ngl3 deletion does not affect inhibitory synaptic input in the hippocampus
but increases the excitatory drive by enhancing excitatory synaptic input.
The increased excitatory drive in the hippocampus could be attributable to enhanced excit-
atory inputs from outside the hippocampus but could also involve increased neuronal excit-
ability within the hippocampus. Intriguingly, neuronal excitability was significantly increased
in Ngl3−/−(Hyb) CA1 pyramidal neurons, measured as spike counts induced by injected
long-term depression; LTP, long-term potentiation; NMDAR, NMDA receptor; ns, not significant; P, postnatal day; SC-CA1, Schaffer collateral-CA1
pyramidal; WT-D, wild-type, drug; WT-V, wild-type, vehicle.
https://doi.org/10.1371/journal.pbio.2005326.g005
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currents (Fig 9C). These results suggest that Ngl3 KO leads to enhanced excitatory drive in the
hippocampus.
To test whether the abovementioned changes are associated with any changes in the excit-
atory drive in the whole brain, we induced seizures in Ngl3−/−(Hyb) mice by intraperitoneally
injecting pentylenetetrazol (PTZ) (40 mg/kg). These experiments showed that both seizure-
susceptibility scores and mortality were increased in PTZ-injected Ngl3−/−(Hyb) mice (Fig 9D).
Because the enhanced excitatory drive might be associated with altered brain oscillations, we
Fig 6. Ngl3−/−(Hyb) and Ngl3−/−(B6) mice display hyperactivity. (A) Hyperactivity of Ngl3−/−(Hyb) mice (2–4 months) in the open-field test. Data
are presented as means ± SEM. n = 11 mice for WT and 13 for KO. �P< 0.05, ���P< 0.001, two-way ANOVA with Bonferroni test and Student
t test. (B) Hyperactivity of Ngl3−/−(B6) mice (2–4 months) in the open-field test. Data are presented as means ± SEM. n = 16 mice for WT and 11
for KO. ��P< 0.01, ���P< 0.001, ns, not significant, two-way ANOVA with Bonferroni test and Student t test. (C and D) Hyperactivity of
Ngl3−/−(Hyb) mice (2–4 months) in the Laboras test, in which mouse movements are continuously monitored for 48 hours. Note that rearing, but
not climbing, is increased in Laboras cages, likely reflecting vertical hyperactivity. The 12-hour shades indicate light-off periods. n = 22 mice for
WT and 25 for KO, �P< 0.05, ��P< 0.01, ���P< 0.001, two-way ANOVA with Bonferroni test and Student t test. (E and F) Normal locomotor
activity of Ngl3−/−(B6) mice (2–4 months) in the Laboras test, in which mouse movements are continuously monitored for 48 hours. Note that
rearing, but not climbing, is increased in Laboras cages, likely reflecting vertical hyperactivity. n = 13 mice for WT and 8 for KO, �P< 0.05, ns,
not significant, two-way ANOVA and Student t test. Primary data can be found in S3 Data. KO, knockout; KO-B, knockout, C57BL/6; KO-H,
knockout, hybrid; ns, not significant; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g006
Fig 7. Ngl3−/−(Hyb) and Ngl3−/−(B6) mice display anxiolytic-like behavior. (A) Anxiolytic-like behavior of Ngl3−/−(Hyb) mice (2–4 months) in the elevated plus
maze test, as shown by time spent in open/closed arms. Note that Ngl3−/−(Hyb) mice are also hyperactive in this test. n = 22 mice for WT and 25 for KO,
���P< 0.001, Student t test. (B) Normal anxiety-related behavior of Ngl3−/−(Hyb) mice (2–4 months) in the light-dark test, as shown by transition number and
chamber time. n = 22 mice for WT and 25 for KO; ns, not significant, Student t test. (C) Anxiolytic-like behavior of Ngl3−/−(B6) mice (2–4 months) in the
elevated plus maze test, as shown by time spent in open/closed arms. n = 17 mice for WT and 10 for KO; ���P< 0.001, ns, not significant, Student t test. (D)
Anxiolytic-like behavior of Ngl3−/−(B6) mice (2–4 months) in the light-dark test, as shown by time in the light chamber and transition number. n = 20 mice for
WT and 11 for KO; ��P< 0.01, ���P< 0.001, Student t test. Primary data can be found in S3 Data. KO, knockout; KO-B, knockout, C57BL/6; KO-H,
knockout, hybrid; ns, not significant; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g007
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measured rhythmic oscillations in the frontal and temporal lobes of the Ngl3−/−(Hyb) brain and
found decreased alpha oscillations and increased theta oscillations in the temporal, but not
frontal lobes (Fig 9E, S9 Fig). These results suggest that Ngl3 KO in mice induces an increased
susceptibility to induced seizures that is associated with oscillatory abnormalities.
Fig 8. Ngl3−/−(Hyb) and Ngl3−/−(B6) mice display impaired learning and memory. (A–C) Ngl3−/−(Hyb) mice (2–4 months) display impaired spatial learning and
memory in learning (days 1–7), probe (days 8 and 14), and reversal (days 9–13) phases of the Morris water maze test (days 1–14). Quadrant occupancy and
number of crossings over the location of the former platform during the probe phase on day 8 (B) and on day 14 after the completion of reversal learning (C)
are also indicated. n = 11 mice for WT and 12 for KO; �P< 0.05, ��P< 0.01, ���P< 0.001, ns, not significant, repeated measure of ANOVA, Student t test, and
Mann-Whitney test. (D–F) Ngl3−/−(B6) mice (2–4 months) display impaired spatial learning and memory in learning (days 1–7), probe (days 8 and 14), and
reversal (days 9–13) phases of the Morris water maze test (days 1–14). Quadrant occupancy and number of crossings over the location of the former platform
are indicated for the probe phases on day 8 after the completion of the initial learning phase (B) and on day 14 after the completion of the reversal learning
phase (C). n = 10 mice for WT and 5 for KO; ��P< 0.01, ���P< 0.001, ns, not significant, repeated measure of ANOVA and Student t test. Primary data can be
found in S3 Data. KO, knockout; KO-B, knockout, C57BL/6; KO-H, knockout, hybrid; L, left; ns, not significant; O, opposite; R, right; T, target quadrant; WT,
wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g008
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NMDAR activation rescues hyperactivity and NMDAR currents, but not
anxiolytic-like behavior, in Ngl3−/−(Hyb) mice
The reduced NMDAR-mediated synaptic transmission does not seem to suppress LTP and LTD
in Ngl3−/−(Hyb) mice, as shown by the lack of the rescue effect of DCS on LTP and LTD (Fig 5B
and 5C). However, the reduced NMDAR currents could still suppress the excitability of dendrites
and neuronal output function [52–54], disrupting normal behaviors in Ngl3−/−(Hyb) mice. To this
end, we tested whether DCS could improve the behavioral abnormalities in Ngl3−/−(Hyb) mice.
Fig 9. Enhanced hippocampal excitation, susceptibility to induced seizures, and altered brain oscillations in Ngl3−/−(Hyb) mice. (A and B) Increased frequency and
amplitude of sEPSCs, but normal sIPSCs, in Ngl3−/−(Hyb) hippocampal CA1 pyramidal neurons (P23–25 for sEPSCs and P22–23 for sIPSCs). n = 20 cells from six mice for
WT and 22, 6 for KO (sEPSC); 15, 4 for WT and 15, 3 for KO (sIPSC); �P< 0.05, ns, not significant, Student t test. (C) Increased excitability of Ngl3−/−(Hyb) hippocampal
CA1 neurons (P21–23), as shown by spike counts in response to current injections. n = 14 cells from three mice for WT and KO; �P< 0.05, ��P< 0.01, two-way ANOVA
with Bonferroni test. (D) Enhanced susceptibility to PTZ-induced seizures in Ngl3−/−(Hyb) mice (3 months), as shown by seizure susceptibility score and mortality. n = 15
mice for WT and 14 for KO; �P< 0.05, ��P< 0.01, Student t test. (E) Decreased alpha and increased theta oscillations in the temporal, but not frontal, lobes of the Ngl3−/
−(Hyb) brain (3 months), as shown by the power spectrum and normalized power in different frequency ranges. Frequency ranges in Hz were defined as follows: delta, 1–4;
theta, 4–8; alpha, 8–13; beta, 13–30; gamma, 30–100. n = 6 mice for WT and KO; �P< 0.05, ���P< 0.001, ns, not significant, Student t test. Primary data can be found in
S3 Data. CA1, Cornu Ammonis 1; F-I curve, firing-I (current) curve; KO, knockout; KO-H, knockout, hybrid; ns, not significant; P, postnatal day; PTZ, pentylenetetrazol;
sEPSC, spontaneous EPSC; sIPSC, spontaneous IPSC; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2005326.g009
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We did not test whether Akt inhibition could correct the abnormal behaviors because the Akt
inhibitor IV, although known to be membrane permeable, has been used only for in vitro studies
[38–40], lacking information on blood-brain barrier (BBB) penetrance and pharmacokinetic
properties.
Treatment of Ngl3−/−(Hyb) mice with DCS (20 mg/kg, intraperitoneal) 30 minutes before the
open-field test reduced hyperactivity in these animals (Fig 10A). In contrast, DCS did not
affect the locomotor activity of WT mice. The effect of DCS on time spent in the center region
(center time) could not be assessed because the center time after drug injection became com-
parable in vehicle-treated Ngl3−/−(Hyb) and WT mice, suggesting sensitivity to handling or
injection procedures. In another pharmacological rescue experiment, CDPPB (10 mg/kg,
intraperitoneal), a positive allosteric modulator of metabotropic glutamate receptor 5
Fig 10. NMDAR activation rescues hyperactivity and NMDAR currents, but not anxiolytic-like behavior, in Ngl3−/−(Hyb) mice. (A) DCS (20 mg/kg,
intraperitoneal) or vehicle (saline), administered into the WT and Ngl3−/− mice 30 minutes before the test, rapidly rescues the hyperactivity of Ngl3−/− mice (2–
3 months) without an effect on WT mice in the open-field test, as shown by the distance moved. n = 11 mice for WT-saline (V), 12 for WT-DCS (D), 13 for
KO-V, and 15 for KO-D; �P< 0.05, ���P< 0.001, ns, not significant, two-way ANOVA with Bonferroni test. (B) DCS does not affect the anxiolytic-like
behavior of Ngl3−/− mice (2–3 months) in the elevated plus maze test, as shown by time in open/closed arms. Note that the hyperactivity of Ngl3−/− mice on the
elevated plus maze was not improved by DCS. n = 14 mice for WT-V, 12 for WT-D, 16 for KO-V, and 15 for KO-D; ��P< 0.01, ���P< 0.001, ns, not
significant, two-way ANOVA with Bonferroni test. (C) DCS rescues NMDAR function at SC-CA1 synapses of Ngl3−/− mice (P16–20), as shown by the NMDA/
AMPA ratio. n = 10 slices from seven mice for WT-V; 8, 6 for WT-D; 10, 9 for KO-V; and 7, 5 for KO-D; �P< 0.05, ���P< 0.001, ns, not significant, two-way
ANOVA with Bonferroni test. Primary data can be found in S3 Data. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; DCS, D-cycloserine;
KO-D, knockout, drug; KO-V, knockout, vehicle; NMDA, N-methyl-D-aspartate; NMDAR, NMDA receptor; ns, not significant; SC-CA1, Schaffer collateral-
CA1 pyramidal; WT, wild-type; WT-D, wild-type, drug; WT-V, wild-type, vehicle.
https://doi.org/10.1371/journal.pbio.2005326.g010
NGL-3 in brain development, synaptic plasticity, and behaviors
PLOS Biology | https://doi.org/10.1371/journal.pbio.2005326 June 5, 2019 16 / 30
(mGluR5) that can potentiate NMDARs [55], similarly rescued the hyperactivity in Ngl3−/
−(Hyb) mice without affecting the center time (S10 Fig).
In contrast to the positive effect of DCS on hyperactivity in an open-field context, DCS did
not improve the anxiolytic-like behaviors of Ngl3−/−(Hyb) mice in the elevated plus maze test, as
shown by the time spent in open and closed arms (Fig 10B). DCS also had no effect on the
total distance moved in the elevated plus maze. Taken together, these results suggest that DCS
rapidly rescues open-field hyperactivity in Ngl3−/−(Hyb) mice. We did not test the effect of DCS
on learning and memory impairments of Ngl3−/−(Hyb) mice in the Morris water maze test
because this test would have required repeated drug treatments during a large number of ses-
sions over multiple days.
Finally, we tested whether DCS, which rescued hyperactivity in Ngl3−/−(Hyb) mice, also res-
cues NMDAR function in these mice. DCS rapidly restored NMDAR function at SC-CA1
Ngl3−/−(Hyb) synapses, as measured by the NMDA/AMPA ratio (Fig 10C), although it did not
normalize LTP or LTD in the Ngl3−/−(Hyb) hippocampus, as mentioned above (Fig 5B and
5C). Notably, DCS also increased NMDAR function at WT synapses, albeit to a lesser extent,
although it had only minimal effects on the behavior of WT mice. These results collectively
suggest that elevation of NMDAR-mediated currents, but not the correction of synaptic plas-
ticity, rescues hyperactivity but not anxiolytic-like behavior in Ngl3−/−(Hyb) mice.
Discussion
Our data indicate that Ngl3 KO in mice in the context of a pure genetic background has signifi-
cant impacts on neurodevelopmental processes, affecting birth rate, postnatal growth and sur-
vival, and brain development (Fig 1). How might Ngl3 KO exert such strong
neurodevelopmental effects? NGL-3 is mainly expressed in the brain and directly interacts
with important synaptic proteins, such as PSD-95 family proteins and presynaptic LAR-RPTPs
[20–22]. However, mice lacking PSD-95 do not display severe neurodevelopmental deficits
[56]. Instead, they show impaired spatial learning associated with abnormal synaptic plasticity
that is qualitatively different from those observed in Ngl3−/−(B6) mice; for instance, PSD-95–
deficient mice show normal NMDAR-mediated synaptic transmission but enhanced LTP at all
tested stimulation frequencies, including 1-Hz stimulation, which usually induces LTD [56].
Therefore, PSD-95 is less likely to be involved in the developmental phenotypes observed in
Ngl3−/−(B6) mice.
LAR-RPTPs are known to regulate not only synapse development but also early neurodeve-
lopmental processes such as axon outgrowth and guidance [1, 4, 57]. In addition, mice lacking
LAR-RPTPs such as PTPσ and PTPδ display severe developmental phenotypes, including peri-
and postnatal semilethality and postnatal growth [58–60]. Moreover, our data indicate that syn-
aptic levels of two LAR-RPTP family proteins (PTPδ and PTPσ) are decreased in Ngl3−/−(B6)
mice (S2 Fig). Therefore, Ngl3 KO may dysregulate early developmental processes through the
loss of trans-synaptic or interneuronal interactions of NGL-3 with LAR-RPTPs. In line with this
possibility, NGL-3 proteins are detected at substantial levels at embryonic day 18 and P1 (earlier
stages were not tested) in addition to relatively late postnatal stages in rats [22].
It has been shown that, in addition to interacting with NGL-3, LAR-RPTPs interact with
other postsynaptic adhesion molecules, including TrkC, IL1RAPL1, IL1RAcP, Slitrks, and
SALM3/5 [19, 21–30]. However, mice lacking some of these molecules, such as TrkC [61],
IL1RAPL1 [62, 63], Slitrk1/3/5 [27, 64, 65], and SALM3 [29], do not show severe neurodeve-
lopmental phenotypes involving altered birth rates, growth, or survival, although they do show
relatively minor, but important, phenotypes such as deficits in synapse development, sensory
function, and specific behaviors. These results suggest that, among many LAR-RPTP–
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interacting postsynaptic adhesion molecules, NGL-3 plays a more important role in the regula-
tion of neurodevelopmental processes.
Then, why is NGL-3 more important for neurodevelopment processes among known
LAR-RPTP–interacting postsynaptic adhesion molecules? Notably, our data associate Ngl3 KO
with enhanced Akt/GSK3β phosphorylation in the brain (Fig 4). Akt is a fundamental regula-
tor of cellular development and function, including cell cycle regulation [66–68]. In the central
nervous system, Akt has been extensively associated with brain development and neurodeve-
lopmental disorders [69–71]. In addition, many substrates of Akt, including GSK3β, are impli-
cated in brain development and disorders [72, 73]. These results suggest that Ngl3 KO may
impair brain development through altered Akt/GSK3β signaling.
Unexpectedly, and in contrast to in vitro results supporting the idea that NGL-3 promotes
excitatory synapse development, Ngl3 KO had minimal impacts on excitatory synapse develop-
ment and AMPAR-mediated basal transmission (Fig 2). It is possible that the impacts of Ngl3
KO may be dampened by other LAR-RPTP–interacting postsynaptic adhesion molecules.
Notably, mice with TrkC knockdown [23] and those with IL1RAPL1 [62, 63] or SALM3 [29]
KO show particularly strong reductions in excitatory synapses and dendritic spines, suggesting
that these molecules have stronger influences on LAR-RPTP–dependent excitatory synapse
development.
Our data indicate that Ngl3 KO leads to moderate reductions in NMDAR-dependent syn-
aptic transmission and LTP (Fig 3), reminiscent of other synaptic adhesion molecules that
affect NMDARs, including neuroligin-1 [74], neuroligin-3 [75], leucine rich repeat transmem-
brane protein 2 (LRRTM2) [76], erythropoietin producing human hepatocellular receptor Bs
or ephrin receptor Bs (EphBs) [77], and fibronectin leucine rich transmembrane protein 3
(FLRT3) [78]. A quantitative analysis indicated that LTP was decreased by approximately 32%
and 40% in Ngl3−/−(Hyb) and Ngl3−/−(B6) mice, respectively, similar to the extent of the reduc-
tion in NMDAR-mediated transmission (approximately 28% and 18%, respectively). However,
NMDAR activation by DCS does not rescue the suppressed LTP in Ngl3−/−(Hyb) mice (Fig 5B),
suggesting that reduced NMDAR currents do not suppress LTP. It is possible that some signal-
ing pathways in the downstream of NMDAR activation that regulate synaptic delivery of
AMPARs [79, 80] might have been changed. In addition, the mechanisms underlying the
reduced NMDAR currents in Ngl3−/− mice remain unclear. Our data suggest that the reduced
NMDAR currents are unlikely to involve altered surface trafficking of NMDARs (Fig 4C) or
changes in the subunit composition of NMDARs, based on the normal decay kinetics (Fig 3A
and 3B). It is possible, again, the strongly altered Akt/GSK3β signaling and related signaling
molecules might alter the phosphorylation and function of NMDARs [32] in Ngl3−/−(Hyb)
mice.
Intriguingly, LTD is almost completely abolished in Ngl3−/−(Hyb) mice. This does not seem
to involve reduced NMDAR currents because DCS does not rescue LTD (Fig 5C). Impor-
tantly, activities of Akt and GSK3β, signaling molecules known to regulate LTD [35, 36], are
changed towards the direction that suppresses LTD (increased Akt and decreased GSK3β
activities) (Fig 4D). In addition, Akt inhibition rapidly and strongly normalizes LTD in Ngl3−/
−(Hyb) slices (Fig 5A). Mechanisms underlying the strong changes in Akt/GSK3β signaling
induced by Ngl3 KO remain unclear. However, the C-terminal tail of NGL-3 directly interacts
with PSD-95 family proteins [22] known to coordinate various synaptic signaling pathways
[81, 82]. In addition, because LTD is known to refine neural circuits by redistributing synaptic
proteins to more active synapses, it is conceivable that the near-complete elimination of LTD
in Ngl3−/− mice, which manifests in both genetic backgrounds, may contribute to the observed
neurodevelopmental deficits and behavioral abnormalities.
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Ngl3 KO appears to be abnormally enhancing brain excitation in Ngl3−/−(Hyb) mice, as evi-
denced by increases in sEPSC frequency (but not mEPSC frequency) and intrinsic neuronal
excitability in the hippocampus, and increased susceptibility to induced seizures (Fig 9). This
increase in the excitatory drive may represent a compensatory mechanism within the hippo-
campus to counteract the reduction in NMDAR function. Alternatively, it could be the conse-
quences of Ngl3 KO in brain regions other than the hippocampus. In support of this latter
possibility, NGL-3 mRNA is widely expressed in various brain regions, including those
enriched for GABAergic neurons, such as the striatum [17, 21]. In addition, our fluorescence
in situ hybridization directly indicates that Ngl3 mRNAs are detected in both excitatory and
inhibitory neurons (S8 Fig). Therefore, Ngl3 KO in inhibitory neurons might suppress the out-
put functions of these neurons, resulting in the excitation of target excitatory neurons and the
overall excitatory drive in the brain, although this does not seem to be the case in the hippo-
campus (normal mIPSCs and sIPSCs). However, we could observe altered alpha and theta
oscillations in the temporal cortex of Ngl3−/−(Hyb) mice, a result that may reflect disrupted
interplay of excitatory and inhibitory neurons.
Behaviorally, Ngl3−/−(Hyb) mice display abnormal hyperactivity, anxiolytic-like behaviors,
and impaired spatial and motor learning and memory; however, recognition learning and
memory were unchanged (Figs 6–8 and S5 Fig). These results suggest that, although NGL-3 is
widely expressed in various brain regions, Ngl3 KO leads to specific behavioral deficits. We
also found that pharmacological enhancement of NMDAR currents by acute DCS treatment
normalizes hyperactivity, but not anxiolytic-like behavior, in Ngl3−/−(Hyb) mice (Fig 10).
Although DCS did not rescue LTP or LTD (Fig 5B and 5C), enhanced NMDAR currents
would increase the excitability of postsynaptic dendrites and neurons, increasing their output
functions and disrupting related neural circuits [52–54].
Although NGL-3 by itself has not been directly implicated in any particular brain disorders,
its presynaptic LAR-RPTP binding partners have been extensively linked to various psychiatric
disorders [1, 4]. For example, PTPδ has been associated with restless leg syndrome [42–44],
ADHD [45], ASD [46], and bipolar disorder [47]. Given that deletion of trans-synaptic part-
ners (e.g., NGL-2 and its presynaptic ligand netrin-G2) in mice often results in phenotypic
similarities [83–86], the abnormalities at the synapse, systems, and behavioral levels observed
in Ngl3−/− mice may help us understand how LAR-RPTPs are associated with specific psychiat-
ric disorders.
Associating all the phenotypes observed in Ngl3−/−(Hyb) and Ngl3−/−(B6) mice is a great chal-
lenge, but the following questions could be raised. How does the change in the genetic back-
ground dramatically improve brain development and mouse survival? How do the changes in
synaptic signaling and synaptic plasticity, in particular in LTD, impair multiple behaviors in
the mutant mice? The beneficial effects of a hybrid background on brain development and sur-
vival may be attributable to the suppression of the homozygosity of certain genetic traits under
a single genetic background that causes certain harmful effects. Indeed, it has been shown that
mice in hybrid genetic backgrounds show higher viability and better performance in behav-
ioral tests such as complex learning and memory tasks [87–89]. Identification of specific chro-
mosomal loci or genes using genetic methods such as quantitative trait loci (QTL) analyses,
genome wide association studies (GWAS), and exome/genome sequencing would eventually
lead to the identification of related mechanisms, although they would have to be pursued in
future studies. The impaired LTD during the critical period of activity-dependent excitatory
synapse and circuit refinement during brain development might suppress the sharpening pro-
cess of certain synapses and circuits required for specific behaviors. In addition, the altered
Akt/GSK3β signaling in Ngl3−/− mice, known to affect numerous synaptic and non-synaptic
target proteins and be associated with various brain disorders, including schizophrenia,
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Alzheimer disease, and bipolar disorder [72, 90–94], may alter the synaptic, neuronal, and cir-
cuit functions.
It remains unknown whether mutations in the human LRRC4B gene encoding NGL-3 are
associated with brain disorders. However, presynaptic binding partners of NGL-3 such as
PTPδ and PTPσ have been implicated in multiple brain disorders, including restless leg syn-
drome, attention deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder,
Alzheimer disease, obsessive compulsive disorder, addiction, and mood liability [1, 4, 95]. In
addition, NGL-3 has been reported as a novel and LTD-dependent substrate of matrix metallo-
proteinases and the presenilin/γ-secretase complex [96], known to be associated with diverse
brain disorders including Alzheimer disease and multiple sclerosis [97–100]. It is therefore
possible that NGL-3 might contribute to some of the pathophysiological mechanisms underly-
ing these brain disorders.
In conclusion, our results suggest that NGL-3 regulates neurodevelopment, Akt/GSK3β sig-
naling, LTD, brain excitation, and specific behaviors.
Materials and methods
Ethics statement
We used isoflurane anesthetization for slice preparation, and we anesthetized mice with Aver-
tin (tribromoethanol, 20 mg/mL) for EEG.
Mice were bred and maintained according to the Requirements of Animal Research at
Korea Advanced Institute of Science and Technology (KAIST), and all procedures were
approved by the Committee of Animal Research at KAIST (KA2016-27).
Generation and characterization of Ngl3−/− mice
Exon 2 of the Ngl3 mice was replaced by a cassette containing the β-geo-puromycin gene and a
polyadenyl action signal by homologous recombination, which were generated by Lexicon
(Stamford, CT) and obtained from Taconic (Rensselaer, NY) (TF2916; F1 generation). We
crossbred these mice with C57BL/6J and 129/Sv mice in parallel at least for five generations.
Ngl3−/−(Hyb) mice were produced by crossbreeding just before experiments. Mice were housed
in a standard cage environment under 12-hour light and dark cycles.
Animal behavioral test
Mice used in all behavioral tests were 2–5 months old. All assays used littermates or age-
matched animals. All behavioral results were analyzed in a blind manner.
Pharmacological rescue
For the rescue of LTD by Akt inhibition, the Akt inhibitor IV (Cayman chemical, 10 μM) was
added to ACSF, and hippocampal slices were exposed to ACSF with Akt inhibitor IV at least
30 minutes before recording. For vehicle treatment, DMSO was added to ACSF. DCS (Sigma,
St. Louis, MO) was dissolved in saline to a final concentration of 5 g/L. WT and Ngl3−/−(Hyb)
mice received an intraperitoneal injection of DCS (20 mg/kg), or the same volume of saline, 30
minutes before behavioral tests. For rescue experiments of the NMDA/AMPA ratio, LTP,
LTD, and NMDAR mEPSC in slice preparations, DCS (20 μM) was added to ACSF. Hippo-
campal slices were exposed to ACSF with DCS at least 30 minutes before recording. For vehicle
treatment, 100 μL of saline was added to ACSF. CDPPB (Ascent Scientific, Cambridge, United
Kingdom) was dissolved in DMSO and PEG400 (DMSO:PEG400 = 1:9) to a final
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concentration of 6 g/L. WT and Ngl3−/−(Hyb) mice received an intraperitoneal injection of
CDPPB (10 mg/kg) or the same volume of DMSO, PEG mixture, 30 minutes before behavioral
tests.
EEG
Mice were anesthetized with Avertin (tribromoethanol, 20 mg/mL) and placed in a stereotaxic
device. Four epidural electrodes for EEG recordings were implanted with connectors
(Omnetics, Minneapolis, MN) in the frontal (2.8 mm anterior and 1.6 mm lateral to bregma)
and temporal cortexes (2.4 mm posterior and 1.6 mm lateral from bregma). A grounding elec-
trode was implanted in the occipital region of the skull. After 7 days of recovery, EEG signals
were recorded for 60 minutes, during which mice were allowed to freely explore their home
cages.
Statistics
Gender, number of mice used, and details of the statistical results are described in S1 Data.
The data with nonparametric distribution were analyzed by Mann-Whitney test, and those
with parametric distribution were analyzed by Student t test. If the data are parametric but
have a significant difference in variance in the F test, Welch correction was used. GraphPad
Prism 7 was used for statistical analysis.
Additional methods can be found in S2 Data.
The numerical data used in all figures are included in S3 Data.
Supporting information
S1 Data. Statistical results.
(XLSX)
S2 Data. Supplementary methods.
(DOCX)
S3 Data. Numerical raw data. Excel spreadsheet containing, in separate sheets, the underlying
numerical data and statistical analysis for figure panels 1A, 1B, 1B, 2A, 2B, 2C, 2D, 2E, 2F, 3A,
3B, 3C, 3D, 3E, 3F, 4A, 4B, 4C, 4D, 5A, 5B, 5C, 6A, 6B, 6C, 6D, 6E, 6F, 7A, 7B, 7C, 7D, 8A, 8B,
8C, 8D, 8E, 8F, 9A, 9B, 9C, 9D, 9E, 10A, 10B, 10C, S2A, S2B, S4A, S4B, S4C, S5A, S5B, S5C,
S5D, S5E, S5F, S5G, S6A, S6B, S6C, S6D, S6E, S6F, S7A, S7B, S7C, S7D, S7E, S7F, S7G, S7H,
S7I, S9A, S9B, S9C, S9D, and S10A.
(XLSX)
S1 Fig. Generation and characterization of Ngl3−/− mice in a C57BL/6J background. (A)
Schematic diagram of the Ngl3 gene KO strategy. (B) PCR genotyping of Ngl3−/− mice. (C)
Lack of detectable NGL-3 protein in whole-brain lysates of Ngl3−/−(B6) mice (8 weeks). (D) A
schematic showing production of Ngl3−/− mice in two different genetic backgrounds: a pure
C57BL/6J background (Ngl3−/−(B6)) and a hybrid 129/Sv + C57B/6J background (Ngl3−/−(Hyb)).
HT, heterozygous; KO, knockout; NGL-3, Netrin-G ligand-3.
(TIF)
S2 Fig. Normal levels of NGL-3 relatives but suppressed levels of PTPδ in the Ngl3−/−(Hyb)
brain. (A and B) Synaptic levels of NGL-3 relatives (NGL-1 and NGL-2) and NGL-3–binding
presynaptic adhesion molecules (PTPδ and PTPσ) were also tested by immunoblot analysis of
crude synaptosomes of the Ngl3−/− brain (3 and 10 weeks). Note that levels of PTPδ are signifi-
cantly reduced at postnatal weeks 3 and 10. n = 4 mice for WT and KO, �P< 0.05, ��P< 0.01,
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Student t test. Primary data can be found in S3 Data. KO, knockout; NGL, Netrin-G ligand;
PTPδ, protein tyrosine phosphatase δ; PTPσ, protein tyrosine phosphatase σ; WT, wild-type.
(TIF)
S3 Fig. Distribution patterns of NGL-3 proteins revealed by X-gal staining and normal
excitatory and inhibitory synaptic signals in the Ngl3−/−(Hyb) hippocampus. (A) Distribu-
tion patterns of NGL-3 proteins, revealed by X-gal staining of Ngl3+/–(Hyb) coronal brain slices
(8–10 weeks). Scale bar, 1 mm. (B and C) Staining of VGluT1 (excitatory presynaptic marker)
and VGAT (inhibitory presynaptic marker) in the hippocampus in Ngl3−/−(Hyb) mice (10
weeks). NGL-3, Netrin-G ligand-3; VGAT, vesicular GABA transporter; VGluT1, vesicular
glutamate transporter 1.
(TIF)
S4 Fig. Ngl3−/−(Hyb) mice show normal inhibitory spontaneous synaptic transmission and
mGluR LTD, but not in NMDAR mEPSC. (A) Normal mIPSCs in hippocampal CA1 neu-
rons of Ngl3−/−(Hyb) mice (P21–23). n = 15 cells from three mice for WT and KO; ns, not signif-
icant, Student t test. (B) Suppressed frequency and amplitude of NMDAR mEPSCs in
hippocampal CA1 neurons of Ngl3−/−(Hyb) mice (P19–20). n = 14 cells from three mice for WT
and 13, 3 for KO; �P< 0.05, Student t test. (C) Normal mGluR-LTD induced by DHPG treat-
ment (50 μM) at hippocampal SC-CA1 synapses of Ngl3−/−(Hyb) mice (P16–20). n = 8, 4 for
WT and 8, 3 for KO; ns, not significant, Student t test. Primary data can be found in S3 Data.
CA1, Cornu Ammonis 1; DHPG, (RS)-3,5-dihydroxyphenylglycine; KO, knockout; mEPSC,
miniature excitatory postsynaptic current; mGluR, metabotropic glutamate receptor; LTD,
long-term depression; mIPSC, miniature inhibitory postsynaptic current; NMDAR, NMDA
receptor; ns, not significant; P, postnatal day; SC-CA1, Schaffer collateral-CA1 pyramidal;
WT, wild-type.
(TIF)
S5 Fig. Ngl3−/−(B6) and Ngl3−/−(B6) mice show normal social interaction and novel-object rec-
ognition. (A) Normal social interaction and social novelty recognition in Ngl3−/−(Hyb) mice (2–
4 months) in the three-chamber social interaction test, as shown by time spent sniffing. n = 7
mice for WT and 6 for KO. ���P< 0.001, ns, not significant, one-way ANOVA with Tukey mul-
tiple comparison test. (B) Normal self-grooming and marble burying in Ngl3−/−(Hyb) mice (2–4
months). n = 11 mice for WT and 12 for KO for self-grooming, n = 14 mice for WT and 11 for
KO for marble burying test; ns, not significant, Student t test. (C) Normal social interaction
and social novelty recognition of Ngl3−/−(B6) mice (2–4 months) in the three-chamber social
interaction test, as shown by time spent sniffing. n = 7 mice for WT and 6 for KO; �P< 0.05,
��P< 0.01, ���P< 0.001, one-way ANOVA with Tukey test. (D) Normal object recognition
memory in Ngl3−/−(Hyb) mice (2–4 months) in the novel-object recognition test. n = 15 mice for
WT and 11 for KO; ns, not significant, Student t test. (E) Normal fear memory of Ngl3−/−(Hyb)
mice (2–4 months) in the contextual fear conditioning test. n = 13 mice for WT and 10 for KO;
ns, not significant, Student t test. (F) Normal object recognition of Ngl3−/−(B6) mice (2–4
months) in the novel-object recognition test. n = 15 mice for WT and 11 for KO; ns, not signifi-
cant, Student t test. (G) Impaired motor learning of Ngl3−/−(Hyb) mice (2–4 months) in the
rotarod test. n = 11 mice for WT and 12 for KO; ���P< 0.001, two-way ANOVA with Bonfer-
roni test. Primary data can be found in S3 Data. KO, knockout; ns, not significant; WT, wild-
type.
(TIF)
S6 Fig. Heterozygosity of Ngl3 in mice does not affect synaptic transmission or plasticity in
the hippocampus. (A and B) Normal mEPSCs and mIPSCs in Ngl3+/–(B6) hippocampal CA1
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neurons (P17–23 for mEPSCs and P18–22 for mIPSCs). n = 16 cells from five mice for WT and
13, 5 for KO (mEPSC); 12, 4 for WT and 15, 5 for KO (mIPSC); ns, not significant, Student t
test. (C and D) Normal input-output relationship and paired-pulse ratio at Ngl3+/–(B6) hippo-
campal SC-CA1 synapses (P27–29), as shown by fEPSP slopes plotted against fiber volley ampli-
tudes and paired-pulse ratios plotted against inter-pulse intervals. n = 10 cells from three mice
for WT and KO for both input-output and paired-pulse ratio, two-way ANOVA with Bonfer-
roni test. (E) Normal NMDAR function at Ngl3+/–(B6) hippocampal SC-CA1 synapses (P17–23),
as shown by the NMDA/AMPA ratio. n = 8 cells from five mice for WT and 8, 7 for KO; ns, not
significant, Student t test. (F) Normal LTP induced by HFS (100 Hz, 1 second) at Ngl3+/–(B6)
hippocampal SC-CA1 synapses (P23–33). n = 8 slices from six mice for WT and 10, 7 for KO;
ns, not significant, Student t test. Primary data can be found in S3 Data. AMPA, α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid; CA1, Cornu Ammonis 1; fEPSP, field excit-
atory postsynaptic potential; KO, knockout; LTP, long-term potentiation; mEPSC, miniature
excitatory postsynaptic current; mIPSC, miniature inhibitory postsynaptic current; NMDA, N-
methyl-D-aspartate; NMDAR, NMDA receptor; P, postnatal day; SC-CA1, Schaffer collateral-
CA1 pyramidal; WT, wild-type.
(TIF)
S7 Fig. Heterozygous Ngl3+/–(B6) mice show moderate hypoactivity and anxiolytic-like
behavior. (A) Moderate hypoactivity of Ngl3+/–(B6) mice (2–4 months) in the open-field test.
Mean ± SEM. n = 20 mice for WT and heterozygote (HT); �P< 0.05, two-way ANOVA with
Bonferroni test and Student t test. (B) Normal locomotor activity of Ngl3+/–(B6) mice (2–4
months) in the Laboras test, in which mouse movements are continuously monitored for 48
hours. n = 15 mice for WT and HT; ns, not significant, two-way ANOVA with Bonferroni test
and Student t test. (C) Normal anxiety-like behavior of Ngl3+/–(B6) mice (2–4 months) in the
elevated plus maze test, as shown by time spent in and entries into open/closed arms. n = 9
mice for WT and 8 for HT; ns, not significant, Student t test. (D) Moderate anxiolytic-like
behavior of Ngl3+/–(B6) mice (2–4 months) in the light-dark test, as shown by transition num-
ber and chamber time. n = 18 mice for WT and 17 for HT; �P< 0.05, ns, not significant, Stu-
dent t test. (E) Normal object memory of Ngl3+/–(B6) mice (2–4 months) in the novel-object
recognition test. n = 20 mice for WT and 19 for HT; ns, not significant, Student t test. (F) Nor-
mal motor learning of Ngl3+/–(B6) mice (2–4 months) in the rotarod test. n = 10 mice for WT
and HT; ns, not significant, repeated measure of ANOVA. (G) Normal social interaction and
social novelty recognition of Ngl3+/–(B6) mice (2–4 months) in the three-chamber social inter-
action test, as shown by time spent in sniffing. n = 12 mice for WT and 10 for HT;
���P< 0.001, one-way ANOVA with Tukey test. (H) Normal spatial memory of Ngl3+/–(B6)
mice (2–4 months) in the learning, probe, and reversal phases of the Morris water maze test.
Quadrant occupancy during the probe phase is also indicated. n = 10 mice for WT and 9 for
HT; ��P< 0.01, ns, not significant, two-way ANOVA with Bonferroni test and Student t test.
(I) Normal fear memory of Ngl3+/–(B6) mice (2–4 months) in the contextual fear conditioning
test. n = 12 mice for WT and KO; ns, not significant, Student t test. Primary data can be found
in S3 Data. HT, heterozygote; ns, not significant; WT, wild-type.
(TIF)
S8 Fig. Localization of Ngl3/Lrrc4b mRNAs in both excitatory and inhibitory neurons. (A
and B) Localization of Ngl3/Lrrc4b mRNAs in both excitatory and inhibitory neurons in the
cortex and hippocampus of WT mice (P56), as determined by fluorescence in situ hybridiza-
tion and shown by the colocalization of Ngl3/Lrrc4b mRNAs and Vglut1/2 (excitatory neuro-
nal marker) or Gad1/2 (inhibitory neuronal marker). Arrowheads indicate examples of
neurons that express both Ngl3/Lrrc4b and Vglut1/2 or Gad1/2 mRNAs. Scale bar, 0.2 mm
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(left) and 20 μm (right). Gad1/2, glutamate decarboxylase 1/2; Ngl3/Lrrc4b, Netrin-G ligand-
3/Leucine-rich repeat-containing protein 4B; P, postnatal day; Vglut1/2, vesicular glutamate
transporter 1/2; WT, wild-type.
(TIF)
S9 Fig. Brain oscillations in Ngl3−/−(Hyb) mice. (A-D) Total power of brain oscillations (A)
and brain oscillations in different frequency ranges, normalized to the total power (B–D).
Note that none of the comparisons yielded significant differences except alpha and theta
ranges in the temporal lobe (see main figure panels). n = 6 mice for WT and KO; ns, not signif-
icant, Student t test. Primary data can be found in S3 Data. KO, knockout; ns, not significant;
WT, wild-type.
(TIF)
S10 Fig. CDPPB rescues hyperactivity in Ngl3−/−(Hyb) mice. (A) CDPPB (10 mg/kg, intraper-
itoneal), administered 30 minutes before the test, rapidly rescues the hyperactivity of Ngl3−/−
mice (2–3 months) in the open-field test, as shown by the distance moved. n = 11 mice for
WT-saline (V), 12 for WT-DCS (D), 17 for KO-V, and 18 for KO-D; �P< 0.05, ���P< 0.001,
ns, not significant, two-way ANOVA with Bonferroni test. Primary data can be found in S3
Data. DCS, D-cycloserine; KO-D, knockout, drug; KO-V, knockout, vehicle; ns, not signifi-
cant; V, vehicle; WT, wild-type.
(TIF)
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